The influence of cytokines on wakefulness regulation: Clinical relevance, mechanisms and methodological problems

Psychiatria Danubina

Volumn 24, Issue 2, 2012, Pages 112-126

  Weschenfelder, Julia ^a   Sander, Christian ^a   Kluge, Michael ^a   Kirkby, Kenneth Clifford ^b   Himmerich, Hubertus ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Cytokines; Sleepiness; Vigilance; Wakefulness

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; CLOZAPINE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLUTAMIC ACID; GROWTH HORMONE RELEASING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NORADRENALIN; OLANZAPINE; PROSTAGLANDIN D2; TUMOR NECROSIS FACTOR ALPHA;

ACCIDENT; ALERTNESS; AROUSAL; ATTENTION DEFICIT DISORDER; BIOCHEMISTRY; BRAIN REGION; DAYTIME SOMNOLENCE; DEPRESSION; DROWSINESS; FATIGUE; FOREBRAIN; HUMAN; ILLNESS BEHAVIOR; IMMUNE SYSTEM; LOGORRHEA; MENTAL DISEASE; METABOLIC DISORDER; NARCOLEPSY; NEUROANATOMY; REVIEW; SIGNAL TRANSDUCTION; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE; WAKEFULNESS; BRAIN; IMMUNOLOGY; MOOD DISORDER; PHYSIOLOGY;

BRAIN; CYTOKINES; HUMANS; MOOD DISORDERS; SLEEP DISORDERS; WAKEFULNESS;

EID: 84864873970     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (183)

1. Afari N & Buchwald D: Chronic fatigue syndrome: a review. Am J Psychiatry 2003; 160:221-36.
2. Ahn KS & Aggarwal BB: Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 2005; 1056:218-33.
3. Åkerstedt T & Gillberg M: Subjective and objective sleepiness in the active individual. Int J Neurosci 1990; 52:29-37.
4. Alam M, McGinty D, Bashir T, Kumar S, Imeri L, Opp MR et al.: Interleukin-1b modulates state-dependent discharge activity of preoptic area and basal forebrain neurons: role in sleep regulation. Eur J Neurosci 2004; 20:207-16.
5. American Sleep Disorders Association Diagnostic Classification Steering Committee: International classification of sleep disorders. Diagnostic and coding manual. American Sleep Disorders Association, Rochester, 1990.
6. Annual Estimates of the Resident Populations by Sex and Selected Age Groups for the United States: April 1, 2000 to July 1, 2009. US Census Bureau, Washington, DC, 2009.
7. Arias-Carrión O, Huitrón-Reséndiz S, Arankowsky-Sandoval G & Murillo-Rodríguez E: Biochemical modulation of the sleep-wake cycle: Endogenous sleep-inducing factors. J Neurosci Res 2011; 89:1143-9.
8. Arrigoni E, Mochizuki T & Scammell TE: Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol (Oxf) 2010; 198:223-35.
9. Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S et al.: Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010; 11: CD006633.
10. Bach DR, Friston KJ & Dolan RJ: Analytic measures for quantification of arousal from spontaneous skin conductance fluctuations. Int J Psychophysiol 2010; 76:52-5.
11. Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S & Ford B: Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun 2012; 26:24-31.
12. Basheer R, Rainnie DG, Porkka-Heiskanen T, Ramesh V & McCarley RW: Adenosine, prolonged wakefulness, and A1-activated NF-κB DNA binding in the basal forebrain of the rat. Neuroscience 2001; 104:731-9.
13. Benca RM, Obermeyer WH, Thisted RA & Gillin JC: Sleep and psychiatric disorders. a meta-analysis. Arch Gen Psychiatry 1992; 49:651-68.
14. Bente D: Vigilanz, dissoziative Vigilanzverschiebung und Insuffizienz des Vigilitätstonus. In Kranz H & Heinrich K (eds): Begleitwirkung und Mißerfolge der psychiatrischen Pharmakotherapie, Thieme, Stuttgart, 1964.
15. Berntson GG, Bigger JT Jr, Eckberg DL, Grossman P, Kaufmann PG, Malik M et al.: Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997; 34:623-48.
16. Berthold-Losleben M, Heitmann S & Himmerich H: Anti-inflammatory drugs in psychiatry. Inflamm Allergy Drug Targets 2009; 8: 266-76.
17. Berthold-Losleben M & Himmerich H: The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology. Curr Neuropharmacol 2008; 6: 193-202.
18. Biswas PN, Wilton LV & Shakir SA: The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England. J Psychopharmacol 2003; 17:121-6.
19. Brambilla D, Franciosi S, Opp MR & Imeri L: Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory post-synaptic potentials. Eur J Neurosci 2007; 26:1862-9.
20. Brandt JA, Churchill L, Rehman A, Ellis G, Mémet S, Israël A et al.: Sleep-deprivation increases activation of nuclear factor kappa B in lateral hypothalamic cells. Brain Res 2004; 1004:91-7.
21. Breder CD, Dinarello CA & Saper CB: Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988; 240:321-4.
22. Bredow S, Guha-Thakurta N, Taishi P, Obál F Jr & Krueger JM: Diurnal variations of tumor necrosis factor a mRNA and a- tubulin mRNA in rat brain. J Neuroimmunomodulation 1997, 4:84-90.
23. Breslau N, Roth T, Rosenthal L & Andreski P: Sleep disturbances and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1997; 39:411-8.
24. Brietzke SA: A personalized approach to metabolic aspects of obesity. Mt Sinai J Med. 2010; 77:499-510.
25. Bryant PA, Trinder J & Curtis N: Sick and tired: does sleep have a vital role in the immune system? Nat Rev Immunol 2004; 4:457-67.
26. Bschor T, Muller-Oerlinghausen B & Ulrich G: Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study. Clin Electroencephalogr 2001; 32:36-9.
27. Cantero JL, Atienza M, Gomez C & Salas RM: Spectral structure and brain mapping of human alpha activities in different arousal states. Neuropsychobiology 1999; 39: 110-6.
28. Cantero JL, Atienza M & Salas RM: Human alpha oscillations in wakefulness, drowsiness period, and REM sleep: different electroencephalographic phenomena within the alpha band. Neurophysiol Clin 2002; 32:54-71.
29. Capuron L & Miller AH: Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011; 130:226-38.
30. Carneiro C, Chaves M, Verardino G, Drummond A, Ramos-e-Silva M & Carneiro S: Fatigue in psoriasis with arthritis. Skinmed 2011; 9:34-7.
31. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP: Development of a fatigue scale. J Psychosom Res 1993; 37:147-53.
32. Chen HY, Cheng IC, Pan YJ, Chiu YL, Hsu SP, Pai MF et al.: Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients. Kidney Int 2011; 80:415-22.
33. Chen L, Duricka D, Nelson S, Mukherjee S, Bohnet SG, Taishi P et al.: Influenza virus-induced sleep responses in mice with targeted disruptions in neuronal or inducible nitric oxide synthases. J Appl Physiol 2004; 97:17-28.
34. Chen Z, Gardi J, Kushikata T, Fang J & Krueger JM: Nuclear factor kappa B-like activity increases in murine cerebral cortex after sleep deprivation. Am J Physiol 1999; 276:1812-8.
35. Chennaoui M, Sauvet F, Drogou C, Van Beers P, Langrume C, Guillard M et al.: Effect of one night of sleep loss on changes in tumor necrosis factor alpha (TNF-α) levels in healthy men. Cytokine 2011; 56:318-24.
36. Dantzer R, O'Connor JC, Freund GG, Johnson RW & Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9:46-56.
37. Dantzer R & Kelley KW: Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 1989; 44:1995-2008.
38. Darko DF, Miller JC, Gallen C, White J, Koziol J, Brown SJ et al.: Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection. Proc Natl Acad Sci U S A 1995; 92:12080-4.
39. Dey S & Snow DM: Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons through TNF-alpha-mediated induction of Bax and phosphorylated c-Jun NH(2)-terminal kinase. J Neurochem 2007; 103:542-56.
40. Dickstein JB, Moldofsky H, Lue FA & Hay JB: Intracerebroventricular injection of TNF-alpha promotes sleep and is recovered in cervical lymph. Am J Physiol 1999; 276:1018-22.
41. Dinarello CA: Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997; 112:321-9.
42. Dinarello CA, Cannon JG & Wolff SM: New concepts on the pathogenesis of fever. Rev Infect Dis 1988; 10: 168-89.
43. Dimitrov S, Lange T, Nohroudi K & Born J: Number and function of circulating human antigen presenting cells regulated by sleep. Sleep 2007; 30: 401-11.
44. Doerr JP, Spiegelhalder K, Petzold F, Feige B, Hirscher V, Kaufmann R et al.: Impact of escitalopram on nocturnal sleep, day-time sleepiness and performance compared to amitriptyline: a randomized, double-blind, placebo-controlled study in healthy male subjects. Pharmacopsychiatry 2010; 43:166-73.
45. Drexhage RC, Hoogenboezem TH, Versnel MA, Berghout A, Nolen WA & Drexhage HA: The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav Immun 2011; 25:1206-13.
46. Dyuizen I & Lamash NE: Histo- and immunocytochemical detection of inducible NOS and TNF-alpha in the locus coeruleus of human opiate addicts. J Chem Neuroanat 2009; 37:65-70.
47. Feinstein DL, Heneka MT, Gavrilyuk V, Dello Russo C, Weinberg G et al.: Noradrenergic regulation of inflammatory gene expression in brain. Neurochem Int 2002; 41:357-65.
48. Feldmann M & Maini RN: The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 1999; 38 Suppl 2:3-7.
49. Ford DE & Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders. an opportunity for prevention? J Am Med Assoc 1989; 262:1479-84.
50. Giedke H & Schwarzler F: Therapeutic use of sleep deprivation in depression. Sleep Med Rev 2002; 6:361-77.
51. Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, Maier SF et al.: Vagal paraganglia bind biotinylated interleukin- 1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull 1997; 43:357-64.
52. Hagiwara H, Araki K, Michimori A & Saito M: A study on the quantitative evaluation method of human alertness and its application. Seishin Shinkeigaku Zasshi 1997; 99: 23-34.
53. Hamilton M: Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 1989; 154:201-6.
54. Hanisch U & Kettenmann H: Microglia: active sensor and versatile effector cells in the normal and pathological brain. Nat Neurosci 2007; 10:1387-94.
55. Harvey AG: Sleep and circadian functioning: critical mechanisms in the mood disorders? Annu Rev Clin Psychol 2011; 7:297-319.
56. Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH & Gold SM: Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 2006; 77: 34-9.
57. Hegerl U, Himmerich H, Engmann B & Hensch T: Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? Curr Opin Psychiatry 2010; 23:1-7.
58. Hegerl U, Sander C, Olbrich S & Schönknecht P: Are psychostimulants a treatment option in mania? Pharmacopsychiatry 2009; 42:169-174.
59. Hegerl U, Wilk K, Olbrich S, Schönknecht P & Sander C: Hyperstable regulation of vigilance in patients with major depressive disorder. World J Biol Psychiatry 2011, Epub.
60. Hemmeter UM, Hemmeter-Spernal J & Krieg JC: Sleep deprivation in depression. Expert Rev Neurother 2010; 10:1101-15.
61. Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D et al.: Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A 2010; 107:6058-63.
62. Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D et al.: Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 2005; 53:697-702.
63. Himmerich H: Neuroimmunologie. In Holsboer H, Gründer G & Benkert O (eds): Handbuch der Psychopharmakologie, 369-374, Springer, Heidelberg, 2007.
64. Himmerich H, Beitinger PA, Fulda S, Wehrle R, Linseisen J, Wolfram G et al.: Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy. Arch Intern Med 2006; 166:1739-43.
65. Himmerich H, Berthold-Losleben M & Pollmächer T: The relevance of the TNF-alpha system in psychiatric disorders. Fortschr Neurol Psychiatr 2009; 77:334-45.
66. Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S et al.: Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 2008;23:421-9.
67. Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S et al.: TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur Cytokine Netw 2006; 17:196-201.
68. Head H: The conception of nervous and mental energy: II. Vigilance: A physiological state of the nervous system. Br J Psychol 1923; 14:126-47.
69. Hinze-Selch D, Schuld A, Kraus T, Kühn M, Uhr M, Haack M et al.: Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine. Neuropsychopharmacology 2000; 23:13-9.
70. Hoddes E, Dement W & Zarcone V: The development and use of the Stanford sleepiness scale. Psychophysiology 1972; 9:150.
71. Hohjoh H, Nakayama T, Ohashi J, Miyagawa T, Tanaka H, Akaza T et al.: Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 1999; 54:138-45.
72. Hohjoh H, Terada N, Kawashima M, Honda Y & Tokunaga K: Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. Tissue Antigens 2000; 56:446-8.
73. Hor H, Kutalik Z, Dauvilliers Y, Valsesia A, Lammers GJ, Donjacour CE et al.: Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010; 42:786-9.
74. Hoving JL, Bartelds GM, Sluiter JK, Sadiraj K, Groot I, Lems WF et al.: Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation. Scand J Rheumatol 2009; 38:246-50.
75. Huang ZL, Urade Y & Hayaishi O. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr Opin Pharmacol 2007; 7:33-8.
76. Imeraj L, Antrop I, Roeyers H, Deschepper E, Bal S & Deboutte D: Diurnal variations in arousal: a naturalistic heart rate study in children with ADHD. Eur Child Adolesc Psychiatry 2011; 20:381-92.
77. Imeri L, Bianchi S & Opp MR: Inhibition of caspase-1 in rat brain reduces spontaneous non-rapid eye movement (NREM) sleep and NREM sleep enhancement induced by lipopolysaccharide. Am J Physiol Regul Integr Comp Physiol 2006; 291:197-204.
78. Janeway C, Travers P, Walport M & Shlomchik M: Immunobiology, 5th ed., Garland Science, New York, 2001.
79. Jones BE: From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 2005; 26:578-86.
80. Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-5.
81. Kalinchuk AV, McCarley RW, Porkka-Heiskanen T & Basheer R: The time course of adenosine, nitric oxide (NO) and inducible NO synthase changes in the brain with sleep loss and their role in the non-rapid eye movement sleep homeostatic cascade. J Neurochem 2011; 116:260-72.
82. Kapsimalis F, Basta M, Varouchakis G, Gourgoulianis K, Vgontzas A & Kryger M: Cytokines and pathological sleep. Sleep Med 2008; 9:603-14.
83. Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW et al.: Cytokine-induced sickness behaviour. Brain Behav Immun 2003; 1:112-8.
84. Keystone E, Burmester GR, Furie R, Loveless JE, Emery P, Kremer J et al.: Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum 2008; 59: 785-93.
85. Khalyfa A, Serpero LD, Kheirandish-Gozal L, Capdevila OS & Gozal D: TNF-α gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr 2011; 158:77-82.
86. Klimesch W: EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Rev 1999; 29:169-95.
87. Kluge M, Himmerich H, Wehmeier PM, Rummel-Kluge C, Dalal M, Hinze-Selch D et al.: Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophr Res 2012, Epub.
88. Kluge M, Schuld A, Schacht A, Himmerich H, Dalal MA, Wehmeier PM et al.: Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 2009; 34:118-28.
89. Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D & Pollmächer T: Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry 2002; 35:220-5.
90. Krueger JM, Obál F Jr & Fang J: Humoral regulation of physiological sleep: cytokines and GHRH. J Sleep Res 1999; 8 Suppl 1:53-9.
91. Krueger JM, Obál FJ, Fang J, Kubota T & Taishi P: The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 2001; 933:211-21.
92. Kronfol Z & Remick DG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157:683-94.
93. Krueger JM & Majide JA: Humoral links between sleep and the immune system. Ann NY Acad Sci 2003; 992:9-20.
94. Krueger JM & Majde JA: Microbial products and cytokines in sleep and fever regulation. Crit Rev Immunol 1994; 14:355-79.
95. Krueger JM, Rector DM & Churchill L: Sleep and Cytokines. Sleep Med Clin 2007; 2:161-9.
96. Krupp LB, Alvarez LA, LaRocca NG & Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988; 45:435-7.
97. Krupp LB, LaRocca NG, Muir-Nash J & Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46:1121-3.
98. Krupp LB & Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 1996; 9:456-60.
99. Kubota T, Kushikata T, Fang J & Krueger JM. Nuclear factor-kappaB inhibitor peptide inhibits spontaneous and interleukin-1beta-induced sleep. Am J Physiol Regul Integr Comp Physiol 2000; 279:404-13.
100. Lange T, Dimitrov S, Bollinger T, Diekelmann S & Born J. Sleep after Vaccination Boosts Immunological Memory. J Immunol 2011; 187:283-90.
101. Lerdal A, Gay CL, Aouizerat BE, Portillo CJ & Lee KA: Patterns of morning and evening fatigue among adults with HIV/AIDS. J Clin Nurs 2011; 20:2204-16.
102. Li LH & Ku BS: Regulation of SWS by hormones and cytokines. Sheng Li Ke Xue Jin Zhan 2000; 31:30-4.
103. Loomis AL, Harvey EN & Hobart GA: Cerebral stats during sleep as studied by human brain potentials. J Exp Psychol 1937; 21:127-144.
104. Lorton D, Lubahn CL, Estus C, Millar BA, Carter JL, Wood CA et al.: Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep. Neuroimmunomodulation 2006; 13:357-74.
105. Lue FA, Bail M, Jephthah-Ochola J, Carayanniotis K, Gorczynski R & Moldofsky H: Sleep and cerebrospinal fluid interleukin-1-like activity in the cat. Int J Neurosci 1988; 42:179-83.
106. Luk WP, Zhang Y, White TD, Lue FA, Wu C, Jiang CG et al.: Adenosine: a mediator of interleukin-1beta-induced hippocampal synaptic inhibition. J Neurosci 1999; 19:4238-44.
107. Mathis J & Hess CW: Sleepiness and vigilance tests. Swiss Med Wkly 2009; 139:214-9.
108. Mackay C, Cox T, Burrows G & Lazzerini T: An inventory for the measurement of self-reported stress and arousal. Br J Soc Clin Psychol 1978; 17:283-4.
109. Makeig S & Jung TP: Changes in alertness are a principal component of variance in the EEG spectrum. Neuroreport 1995; 7:213-6.
110. Manns ID, Lee MG, Modirrousta M, Hou YP & Jones BE: Alpha 2 adrenergic receptors on GABAergic, putative sleep-promoting basal forebrain neurons. Eur J Neurosci 2003; 18:723-7.
111. McCormack PL: Olanzapine: in adolescents with schizophrenia or bipolar I disorder. CNS Drugs 2010; 24:443-52.
112. Merrill JE: Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J Immunother 1992; 12:167-170.
113. Miller LG, Galpern WR, Dunlap K, Dinarello CA & Turner TJ: Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain. Mol Pharmacol 1991; 39:105-8.
114. Minnock P, Kirwan J & Bresnihan B. Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis. Rheumatology 2009; 48:1533-6.
115. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M et al.: Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004; 126:1473-9.
116. Moldofsky H: Fibromyalgia, sleep disorder and chronic fatigue syndrome. Ciba Found Symp 1993; 173:262-71.
117. Mori K, Ozaki E, Zhang B, Yang L, Yokoyama A, Takeda I et al.: Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors. Neuropharmacology 2002; 43:1026-34.
118. Moruzzi G & Magoun HW: Brain stem reticular formation and activation of the EEG. Electroencephalogr Clin Neurophysiol 1949; 1:455-73.
119. Müller N & Ackenheil M: Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22:1-33.
120. Müller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM et al.: Functional role of type I and type II interferons in antiviral defense. Science 1994; 264:1918-21.
121. Munk MH, Roelfsema PR, König P, Engel AK & Singer W: Role of reticular activation in the modulation of intracortical synchronization. Science 1996; 272:271-4.
122. Nas K, Cevik R, Batum S, Sarac AJ, Acar S & Kalkanli S: Immunologic and psychosocial status in chronic fatigue syndrome. Bratisl Lek Listy 2011; 112:208-12.
123. Nishino S & Kanbayashi T: Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005; 9:269-310.
124. Norheim KB, Jonsson G & Omdal R: Biological mechanisms of chronic fatigue. Rheumatology (Oxford) 2011; 50:1009-18.
125. Oades RD, Myint AM, Dauvermann MR, Schimmelmann BG & Schwarz MJ: Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention. Behav Brain Funct 2010; 6:32.
126. Ohayon MM, Caulet M, Philip P, Guilleminault C & Priest RG: How sleep and mental disorders are related to complaints of daytime sleepiness. Arch Intern Med 1997; 157:2645-52.
127. Oken BS, Salinsky MC & Elsas SM: Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol 2006; 117:1885-901.
128. Olbrich S, Mulert C, Karch S, Trenner M, Leicht G, Pogarell O et al.: EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage 2009; 45:319-32.
129. Opp MR: Cytokines and sleep. Sleep Med Rev 2005; 9:355-64.
130. Opp MR & Krueger JM: Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever. Am J Physiol 1991; 260: 453-7.
131. Opp MR & Krueger JM: Anti-interleukin-1 beta reduces sleep and sleep rebound after sleep deprivation in rats. Am J Physiol 1994a; 266:688-95.
132. Opp MR & Krueger JM: Interleukin-1 is involved in responses to sleep deprivation in the rabbit. Brain Res 1994b; 639:57-65.
133. Ormstad H, Aass HC, Amthor KF, Lund-Sørensen N & Sandvik L: Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients. J Neurol 2011; 258:670-6.
134. Perlis ML, Smith LJ, Lyness JM, Matteson SR, Pigeon WR, Jungquist CR et al.: Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med 2006; 4:104-13.
135. Pettipher R: The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses. Br J Pharmacol 2008; 153 Suppl 1:191-9.
136. Pfaff D, Ribeiro A, Matthews J & Kow LM: Concepts and Mechanisms of Generalized Central Nervous System Arousal. Ann NY Acad Sci 2008; 1129:11-25.
137. Pirinen T, Kolho KL, Simola P, Ashorn M & Aronen ET: Parent and self-report of sleep-problems and daytime tiredness among adolescents with inflammatory bowel disease and their population-based controls. Sleep 2010; 33:1487-93.
138. Radomski MW, Buguet A, Bogui P, Doua F, Lonsdorfer A, Tapie P et al.: Disruptions in the secretion of cortisol, prolactin, and certain cytokines in human African trypanosomiasis patients. Bull Soc Pathol Exot 1994; 87:376-9.
139. Raison CL, Rye DB, Woolwine BJ, Vogt GJ, Bautista BM, Spivey JR et al.: Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry 2010; 68:942-9.
140. Redwine L, Hauger RL, Gillin JC & Irwin M: Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab 2000; 85:3597-603.
141. Richardson GS, Carskadon MA, Flagg W, Van den Hoed J, Dement WC & Mitler MM: Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978; 45:621-7.
142. Rosenwasser AM: Functional neuroanatomy of sleep and circadian rhythms. Brain Res Rev 2009; 61:281-306.
143. Roth T, Bogan RK, Culpepper L, Doghramji K, Doghramji P, Drake C et al.: Excessive sleepiness: under-recognized and essential marker for sleep/wake disorder management. Curr Med Res Opin 2010; 26 Suppl 2:3-24.
144. Roth B: Clinical and theoretical importance of EEG rhythms corresponding to states of lowered vigilance. Electroencephalogr Clin Neurophysiol 1961; 13:395-9.
145. Sander C, Arns M, Olbrich S & Hegerl U: EEG-vigilance and response to stimulants in paediatric patients with attention deficit/hyperactivity disorder. Clin Neurophysiol 2010; 121:1511-8.
146. Saper CB, Cano G & Scammell TE: Homeostatic, circadian, and emotional regulation of sleep. J Comp Neurol 2005; 493:92-8.
147. Saper CB, Chou TC & Scammell TE: The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001; 24:726-31.
148. Schönknecht P, Olbrich S, Sander C, Spindler P & Hegerl U: Treatment of acute mania with modafinil monotherapy. Biol Psychiatry 2010; 67:55-57.
149. Schuld A, Haack M, Hinze-Selch D, Mullington J & Pollmächer T: Experimental studies on the interaction between sleep and immune system in humans. Psychother Psychosom Med Psychol 2005; 55:29-35.
150. Serantes R, Arnalich F, Figueroa M, Salinas M, Andrés-Mateos E, Codoceo R et al.: Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. J Biol Chem 2006; 281:14632-43.
151. Shen J, Hossain N, Streiner DL, Ravindran AV, Wang X, Deb P et al.: Excessive daytime sleepiness and fatigue in depressed patients and therapeutic response of a sedating antidepressant. J Affect Disord 2011; 134:421-6.
152. Sherin JE, Shiromani PJ, McCarley RW & Saper CB: Activation of ventrolateral preoptic neurons during sleep. Science 1996; 271:216-9.
153. Sherkat AA, Sardana N, Safaee S, Lehman EB & Craig TJ: The role of pseudoephedrine on daytime somnolence in patients suffering from perennial allergic rhinitis (PAR). Ann Allergy Asthma Immunol 2011; 106:97-102.
154. Shimada M, Miyagawa T, Kawashima M, Tanaka S, Honda Y, Honda M et al.: An approach based on a genome-wide association study reveals candidate loci for narcolepsy. Hum Genet 2010; 128:433-41.
155. Slater JD: A definition of drowsiness: one purpose for sleep? Med Hypotheses 2008; 71:641-4.
156. Smets EM, Garssen B, Bonke B & De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39:315-25.
157. Stedman's Medical Dictionary. Lippincott Williams & Wilkins, 2008.
158. Steiger A: Neurochemical regulation of sleep. J Psychiatr Res 2007; 41:537-52.
159. Steinman L: Elaborate interactions between the immune and nervous systems. Nat Immunol. 2004; 5:575-81.
160. Stroe AF, Roth T, Jefferson C, Hudgel DW, Roehrs T, Moss K et al.: Comparative levels of excessive daytime sleepiness in common medical disorders. Sleep Med 2010; 11:890-6.
161. Sugama S & Conti B: Interleukin-18 and stress. Brain Res Rev. 2008; 58:85-95.
162. Taishi P, Chen Z, Obál F Jr, Hansen MK, Zhang J, Fang J et al.: Sleep-associated changes in interleukin-1beta mRNA in the brain. J Interferon Cytokine Res 1998; 18:793-8.
163. Tabarean IV, Korn H & Bartfai T: Interleukin-1beta induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons. Neuroscience 2006; 141:1685-95.
164. Tauman R, O'Brien LM, Mast BT, Holbrook CR & Gozal D: Peripheral arterial tonometry events and electroencephalographic arousals in children. Sleep 2004; 27:502-6.
165. Thayer RE: Measurement of activation through self-report. Psychol Rep 1967; 20:663-78.
166. Udo T, Bates ME, Mun EY, Vaschillo EG, Vaschillo B et al.: Gender differences in acute alcohol effects on self-regulation of arousal in response to emotional and alcohol-related picture cues. Psychol Addict Behav 2009; 23:196-204.
167. Vanitallie TB: Sleep and energy balance: Interactive homeostatic systems. Metabolism 2006; 55(10 Suppl 2):30-5.
168. Vgontzas AN, Bixler EO & Chrousos GP: Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann N Y Acad Sci 2006; 1083:329-44.
169. Vgontzas AN, Bixler EO, Chrousos GP & Pejovic S: Obesity and sleep disturbances: meaningful sub-typing of obesity. Arch Physiol Biochem 2008; 114:224-36.
170. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K et al.: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82:1313-6.
171. Vgontzas AN, Pejovic S, Zoumakis E, Lin HM, Bixler EO, Basta M et al.: Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion. Am J Physiol Endocrinol Metab 2007; 292:253-61.
172. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A et al.: Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004; 89:2119-26.
173. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G & Chrousos GP: Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004; 89:4409-13.
174. Warm JS, Parasuraman R & Matthews G: Vigilance requires hard mental work and is stressful. Hum Factors 2008; 50:433-41.
175. Watkins LR, Maier SF & Goehler LE: Cytokine-to-brain communication: a review an analysis of alternative mechanisms. Life Sci 1995; 57:1011-26.
176. Watkins LR & Maier SF: The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000; 51:29-57.
177. Weissman MM, Greenwald S, Nino-Murcia G & Dement WC: The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997; 19:245-50.
178. Wichniak A, Geisler P, Tracik F, Crönlein T, Morrissey SP & Zulley J: The influence of polysomnography on the Multiple Sleep Latency Test and other measures of daytime sleepiness. Physiol Behav 2002; 75:183-8.
179. Wilkes S: Bupropion. Drugs Today (Barc) 2006; 42:671-81.
180. Wu JC & Bunney WE: The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 1990; 147:14-21.
181. Young TB: Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence. J Clin Psychiatry 2004; 65 (Suppl 16):12-6
182. Zamarrón C, Maceiras F, Mera A & Gómez-Reino JJ: Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann Rheum Dis 2004; 63:88-90.
183. Zhan S, Cai GQ, Zheng A, Wang Y, Jia J, Fang H et al.: Tumor necrosis factor-alpha regulates the Hypocretin system via mRNA degradation and ubiquitination. Biochim Biophys Acta 2011; 1812:565-71.